ADR 925

Known as: ADR-925 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2018
012319932018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Background:Dexrazoxane (DEX, ICRF-187) is the only clinically approved cardioprotectant against anthracycline cardiotoxicity. It… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
The use of the anthracycline anticancer drugs doxorubicin and daunorubicin is limited by what is thought to be an iron-based… (More)
Is this relevant?
2002
2002
Abstract Purpose. Dexrazoxane is clinically used as a doxorubicin-cardioprotective agent and may act by preventing iron-based… (More)
  • figure 1
  • figure 2
Is this relevant?
2001
2001
Purpose: To compare the protective effect of dexrazoxane (DRZ) against cardiotoxicity induced by doxorubicin (DXR) and… (More)
Is this relevant?
2001
2001
BACKGROUND Recently, we have shown that dexrazoxane (ICRF-187) is an effective antidote against accidental extravasation of… (More)
  • table I
  • figure I
  • figure 4
  • figure 2
  • figure 3
Is this relevant?
1998
1998
The bisdioxopiperazine dexrazoxane (DEX; ICRF-187) has proven to be clinically effective in reducing the cardiotoxicity of… (More)
Is this relevant?
1995
1995
A series of twelve structurally related bisdioxopiperazines that included ICRF-187 (dexrazoxane), ICRF-159 (razoxane), ICRF-193… (More)
Is this relevant?
1994
1994
An HPLC fluorescence detection method was developed to quantitate the complexing agent ADR-925 (II). Compound II is the metal-ion… (More)
Is this relevant?
1993
1993
The ability of the cardioprotective agent ICRF-187 (dexrazoxane), its one-ring open hydrolysis products, and its two-ring open… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1993
1993
The ability of the metal ion binding rings-opened hydrolysis product of the anthracycline cardioprotective agent ICRF-187… (More)
  • figure I
  • figure 2
  • figure 3
  • figure 7
  • table 1
Is this relevant?